2019 Nelson’s Pediatric Antimicrobial Therapy (Original PDF from Publisher)

Cutting-Edge Pediatric Antimicrobial Therapy

This seminal resource in pediatric antimicrobial therapy empowers healthcare providers with the knowledge and tools to combat childhood infectious diseases.

Expert Guidance for Optimal Treatment

For each microbial invader, our seasoned authors offer invaluable commentary, navigating practitioners through the array of antimicrobial choices to select the most effective strategy.

Comprehensive Drug Profiles

Our drug descriptions cater specifically to pediatric patients, providing meticulous information on appropriate antimicrobial selection and precise dosing regimens.

Judicious Antibiotic Use

Amidst concerns over antibiotic misuse, our guide offers wisdom on when antibiotics should be prudently withheld, promoting responsible stewardship of these essential medications.

Enhanced Visual Aids

The vibrant use of color throughout the text expedites the identification of optimal treatment options.

Recent Updates to Enhance Care

The latest edition boasts an array of cutting-edge additions:

• Broad-Spectrum Beta-Lactams and Beta-Lactamase Inhibitors: Recommendations for intravenous combinations to combat resistant infections.
• Escherichia coli Resistance Management: Treatment options for the increasing prevalence of urinary tract infections caused by this resilient pathogen.
• Diarrhea Management Advancements: Aligned with IDSA guidelines, we present recommendations for managing diarrhea, including the use of tinidazole and nitazoxanide as preferred drugs for Giardia infections.
• Fungal Infection Management Refinements: Evolving guidance on therapeutic drug levels for invasive fungal infections, particularly in immunocompromised children.
• Antiviral Table Reorganization: Enhanced readability with consolidated common viral pathogens and separate treatment recommendations for HIV, hepatitis B, and hepatitis C.
• Neonatal Antibacterial Alternatives: In response to the ongoing cefotaxime shortage, we provide alternative options that maintain antibacterial efficacy and safety.
• Neurocysticercosis Updates: Latest recommendations from IDSA and the American Society of Tropical Medicine and Hygiene on drug and steroid therapy for this debilitating infection.
• Coccidioidomycosis Management Guidance: Updated IDSA guidelines integrated into our treatment recommendations.
• Enhanced Navigation: Color-coded tabs and tables facilitate seamless navigation, enabling practitioners to swiftly locate the best treatment options for bacterial, fungal, viral, and parasitic infections.